Skip to main content
Year archive

PharmAbcine Inc. — 2022 filings

All 23 regulatory filings released by PharmAbcine Inc. (208340) in 2022, sourced directly from the official regulator.

23 Filings
2022 Period
2022 filings (23)
Filing Released Lang
투자판단관련주요경영사항(신생혈관성 연령관련 황반변성 환자를 대상으로 PMC-403 단회 및 반복 투여 용량 증량의 안전성 및 내약성을 평가하기 위한 다기관, 공개, 제 1상 임상시험계획 승인 신청)
Regulatory Filings
2022-12-20 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2022-12-15 Korean
[기재정정]분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-11 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
전환가액의조정
Share Issue/Capital Change
2022-07-15 Korean
투자판단관련주요경영사항(2상 임상시험 조기 종료)
Legal Proceedings Report
2022-07-15 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
증권발행결과(자율공시)(제2회차 BW)
Share Issue/Capital Change
2022-04-15 Korean
주요사항보고서(신주인수권부사채권발행결정)
Share Issue/Capital Change
2022-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-03-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-03-25 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-24 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-16 Korean
사업보고서 (2021.12)
Interim / Quarterly Report FY 2021
2022-03-16 Korean
[기재정정]주주총회소집공고
AGM Information
2022-03-16 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-16 Korean
주주총회소집공고
AGM Information
2022-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-08 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제1회차)
Capital/Financing Update
2022-02-28 Korean
주주총회소집결의
AGM Information
2022-02-22 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-08 Korean